Regenerative Medical Technology Group Inc.

PINK:RMTG USA Biotechnology
Market Cap
$420.45K
Market Cap Rank
#38078 Global
#12401 in USA
Share Price
$0.03
Change (1 day)
+0.00%
52-Week Range
$0.03 - $0.03
All Time High
$0.80
About

Regenerative Medical Technology Group Inc. operates in the regenerative medicine industry in the United States and internationally. It provides products, solutions, equipment, services, and training to doctors and their staff in the application of stem cell therapies. The company is also involved in the treatment of patients; provision of training and seminars; and resale of kits, products, equip… Read more

Regenerative Medical Technology Group Inc. - Asset Resilience Ratio

Latest as of March 2018: 0.70%

Regenerative Medical Technology Group Inc. (RMTG) has an Asset Resilience Ratio of 0.70% as of March 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
$15.50K
Cash + Short-term Investments
Total Assets
$2.22 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Regenerative Medical Technology Group Inc.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Regenerative Medical Technology Group Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $15.50K 0.7%
Total Liquid Assets $15.50K 0.70%

Asset Resilience Insights

  • Limited Liquidity: Regenerative Medical Technology Group Inc. maintains only 0.70% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Regenerative Medical Technology Group Inc. Industry Peers by Asset Resilience Ratio

Compare Regenerative Medical Technology Group Inc.'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
MedPacto Inc
KQ:235980
Biotechnology 49.82%
Shenzhen CAU Technology Co Ltd
SHE:000004
Biotechnology 6.20%
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
Biotechnology 6.88%
Nanhua Bio Medicine Co Ltd
SHE:000504
Biotechnology 11.93%
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
Biotechnology 0.03%
Chengzhi Shareholding Co Ltd
SHE:000990
Biotechnology 6.73%
Hualan Biological EngineeringInc
SHE:002007
Biotechnology 14.68%
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030
Biotechnology 4.35%

Annual Asset Resilience Ratio for Regenerative Medical Technology Group Inc. (None–None)

The table below shows the annual Asset Resilience Ratio data for Regenerative Medical Technology Group Inc..

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
No yearly data available.
pp = percentage points